Skip to main content
Erschienen in: European Surgery 6/2012

01.12.2012 | Original Article

Lymph node micrometastases in gastric cancer: final results of the Czech multicentre study

verfasst von: Assoc. Prof. J. Šimša, MD, PhD, Prof. J. Hoch, MD, PhD, B. East, MD, Assoc. Prof. J. Leffler, MD, PhD, Prof. M. Ryska, MD, PhD, Assoc. Prof. F. Bělina, MD, PhD, R. Doležel, MD, PhD, J. Gatěk, MD, PhD, J. Varga, MD

Erschienen in: European Surgery | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Summary

Background:

Lymphadenectomy is an important part of surgical treatment of gastric cancer. Using immunohistochemistry or RT-PCR, small deposits of tumour cells, called micrometastases (MM) and isolated tumour cells (ITC) are found in some of the lymph nodes, which were found negative after a standard examination in haematoxylin eosin (H-E). The aim of this multicentre study was to assess their clinical and prognostic significance.

Methods:

Multicentre, prospective, nonrandomized clinical trial on-going in four Czech centres. The study enrolled patients after radical resection for gastric cancer. All lymph nodes were examined in standard H-E staining, lymph nodes producing negative results were then processed using detailed immunohistochemistry (IHC) with anti-cellular cytokeratin antibody (AE1/AE3, Immunotech).

Results:

A total of 93 patients following radical surgery for gastric cancer, across the four participating centres were included in the study between the 1st January 2009 and 31st December 2011. A total of 42 patients (representing 45.2 % of the cohort) underwent a resection, while the remaining 51 had a total gastrectomy (54.8 %). A total of 1,588 lymph nodes were found and examined, with the average number of nodes per patient being 17.1. Metastases by H-E stain were found in 441 nodes (27.8 %). The remaining lymph nodes which showed negative after processing in H-E were then examined with IHC. Nodular MM was found in 43 nodes (2.7 %), then the ITC in 74 nodes (4.7 %). No statistically significant difference was observed when comparing the length of survival among patients with negative node findings (H-E negative, IHC negative) and patients with minimal node affection (H-E negative, IHC positive), p = 0.494. Likewise there was no statistically significant difference within the sub-group of patients with minimal node affection between patients with micrometastases (MM) and patients with isolated tumour cells (ITC), p = 0.925.

Conclusions:

The results of this study indicate that the presence of nodal MM and ITC in gastric cancer is not linked to the worsening of the prognosis of patients. Financially, technically and the time-consuming method of processing nodes with IHC cannot yet be recommended as part of the routine histological examination.
Literatur
1.
Zurück zum Zitat Malignant tumours 2007. Czech National Oncological Register, ÚZIS, 2010. Malignant tumours 2007. Czech National Oncological Register, ÚZIS, 2010.
2.
Zurück zum Zitat Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995;345:745–8.PubMedCrossRef Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995;345:745–8.PubMedCrossRef
3.
Zurück zum Zitat Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet. 1996;347:995–9.PubMedCrossRef Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet. 1996;347:995–9.PubMedCrossRef
4.
Zurück zum Zitat Zheng B, Ma B, Yang K, et al. Meta-analysis of randomized controlled trials comparing D2 and D4 lymphadenectomy for gastric cancer. Eur Surg. 2011;43(5):255–61.CrossRef Zheng B, Ma B, Yang K, et al. Meta-analysis of randomized controlled trials comparing D2 and D4 lymphadenectomy for gastric cancer. Eur Surg. 2011;43(5):255–61.CrossRef
5.
Zurück zum Zitat Gatěk J, Duben J, Bakala J, et al. Lymphadenectomy in early gastric cancer. Rozhl Chir. 2004;83(9):428–35.PubMed Gatěk J, Duben J, Bakala J, et al. Lymphadenectomy in early gastric cancer. Rozhl Chir. 2004;83(9):428–35.PubMed
6.
Zurück zum Zitat Maruyama K, Sasako M, Kinoshita T, et al. Effectiveness of systematic lymph node dissection in gastric cancer surgery. Eur Surg. 1995;27(1):23–7.CrossRef Maruyama K, Sasako M, Kinoshita T, et al. Effectiveness of systematic lymph node dissection in gastric cancer surgery. Eur Surg. 1995;27(1):23–7.CrossRef
7.
Zurück zum Zitat Dostalík J, Martínek L, Satinský I, et al. Laparoscopic total gastrectomy—first experiences. Rozhl Chir. 2003;82(7):353–6.PubMed Dostalík J, Martínek L, Satinský I, et al. Laparoscopic total gastrectomy—first experiences. Rozhl Chir. 2003;82(7):353–6.PubMed
8.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours, UICC. 7th edn. New York: Wiley; 2009. Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours, UICC. 7th edn. New York: Wiley; 2009.
9.
Zurück zum Zitat Kell MR, Winter DC, O’Sullivan GC, et al. Biological behaviour and clinical implications of micrometastases. Br J Surg. 2000;87:1629–39.PubMedCrossRef Kell MR, Winter DC, O’Sullivan GC, et al. Biological behaviour and clinical implications of micrometastases. Br J Surg. 2000;87:1629–39.PubMedCrossRef
10.
Zurück zum Zitat Calaluce R, Miedema BW, Yesus YW. Micrometastasis in colorectal carcinoma: a review. J Surg Oncol. 1998;67(3):194–202.PubMedCrossRef Calaluce R, Miedema BW, Yesus YW. Micrometastasis in colorectal carcinoma: a review. J Surg Oncol. 1998;67(3):194–202.PubMedCrossRef
11.
Zurück zum Zitat Lee E, Chae Y, Kim I, et al. Prognostic relevance of immunohistochemically detected lymph node micrometastasis in patients with gastric carcinoma. Cancer. 2002;94(11):2867–73.PubMedCrossRef Lee E, Chae Y, Kim I, et al. Prognostic relevance of immunohistochemically detected lymph node micrometastasis in patients with gastric carcinoma. Cancer. 2002;94(11):2867–73.PubMedCrossRef
12.
Zurück zum Zitat Yasuda K, Adachi Y, Shiraishi N, et al. Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol. 2002;9(8):771–4.PubMedCrossRef Yasuda K, Adachi Y, Shiraishi N, et al. Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol. 2002;9(8):771–4.PubMedCrossRef
13.
Zurück zum Zitat Harrison LE, Choe JK, Goldstein M, et al. Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients. J Surg Oncol. 2000;73(3):153–7.PubMedCrossRef Harrison LE, Choe JK, Goldstein M, et al. Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients. J Surg Oncol. 2000;73(3):153–7.PubMedCrossRef
14.
Zurück zum Zitat Öberg A, Stenling R, Tavelin B, et al. Are lymph node micrometastases of any clinical significance in Dukes’ stages A and B colorectal cancer? Dis Colon Rectum. 1998;41:1244–9.PubMedCrossRef Öberg A, Stenling R, Tavelin B, et al. Are lymph node micrometastases of any clinical significance in Dukes’ stages A and B colorectal cancer? Dis Colon Rectum. 1998;41:1244–9.PubMedCrossRef
15.
Zurück zum Zitat Isaka N, Nozue M, Doy M, et al. Prognostic significance of perirectal lymph node micrometastases in Dukes’ B rectal carcinoma: an immunohistochemical study by CAM 5.2. Clin Cancer Res. 1999;5:2065–8.PubMed Isaka N, Nozue M, Doy M, et al. Prognostic significance of perirectal lymph node micrometastases in Dukes’ B rectal carcinoma: an immunohistochemical study by CAM 5.2. Clin Cancer Res. 1999;5:2065–8.PubMed
16.
Zurück zum Zitat Yasuda K, Adachi Y, Shiraishi N, et al. Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol. 2001;8(4):300–4.PubMedCrossRef Yasuda K, Adachi Y, Shiraishi N, et al. Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol. 2001;8(4):300–4.PubMedCrossRef
17.
Zurück zum Zitat Čapov I. Bone marrow micrometastasis in a non-small cell lung cancer—initial results. Rozhl Chir. 2003;82(3):145–8.PubMed Čapov I. Bone marrow micrometastasis in a non-small cell lung cancer—initial results. Rozhl Chir. 2003;82(3):145–8.PubMed
18.
Zurück zum Zitat Hejna M, Raderer M, Zielinski CC. Multimodality treatment of gastric cancer. Eur Surg. 2002;34(1):29–31.CrossRef Hejna M, Raderer M, Zielinski CC. Multimodality treatment of gastric cancer. Eur Surg. 2002;34(1):29–31.CrossRef
19.
Zurück zum Zitat Roder JD, Bottcher K, Etter M, et al. Chirurgische und multimodale Behandlung des pT4-Magenkarzinoms. Eur Surg. 1999;31(1):22–5.CrossRef Roder JD, Bottcher K, Etter M, et al. Chirurgische und multimodale Behandlung des pT4-Magenkarzinoms. Eur Surg. 1999;31(1):22–5.CrossRef
Metadaten
Titel
Lymph node micrometastases in gastric cancer: final results of the Czech multicentre study
verfasst von
Assoc. Prof. J. Šimša, MD, PhD
Prof. J. Hoch, MD, PhD
B. East, MD
Assoc. Prof. J. Leffler, MD, PhD
Prof. M. Ryska, MD, PhD
Assoc. Prof. F. Bělina, MD, PhD
R. Doležel, MD, PhD
J. Gatěk, MD, PhD
J. Varga, MD
Publikationsdatum
01.12.2012
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 6/2012
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-012-0178-4

Weitere Artikel der Ausgabe 6/2012

European Surgery 6/2012 Zur Ausgabe